SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-23-003415
Filing Date
2023-01-12
Accepted
2023-01-12 16:27:02
Documents
78

Document Format Files

Seq Description Document Type Size
1 S-1 tm225197-10_drsa.htm S-1 4517649
2 EXHIBIT 3.1 tm225197d11_ex3-1.htm EX-3.1 439082
3 EXHIBIT 4.4 tm225197d11_ex4-4.htm EX-4.4 323892
4 EXHIBIT 10.1 tm225197d11_ex10-1.htm EX-10.1 63022
5 EXHIBIT 10.2 tm225197d11_ex10-2.htm EX-10.2 472401
6 EXHIBIT 10.3 tm225197d11_ex10-3.htm EX-10.3 232357
7 EXHIBIT 10.4 tm225197d11_ex10-4.htm EX-10.4 70512
8 EXHIBIT 10.5 tm225197d11_ex10-5.htm EX-10.5 65340
9 EXHIBIT 10.6 tm225197d11_ex10-6.htm EX-10.6 79902
10 EXHIBIT 10.7 tm225197d11_ex10-7.htm EX-10.7 37632
11 EXHIBIT 10.8 tm225197d11_ex10-8.htm EX-10.8 48445
12 EXHIBIT 10.9 tm225197d11_ex10-9.htm EX-10.9 99919
13 EXHIBIT 10.10 tm225197d11_ex10-10.htm EX-10.10 93775
14 EXHIBIT 10.11 tm225197d11_ex10-11.htm EX-10.11 93958
15 EXHIBIT 10.12 tm225197d11_ex10-12.htm EX-10.12 14037
16 EXHIBIT 10.13 tm225197d11_ex10-13.htm EX-10.13 91606
17 EXHIBIT 10.14 tm225197d11_ex10-14.htm EX-10.14 90522
18 EXHIBIT 10.15 tm225197d11_ex10-15.htm EX-10.15 129618
19 EXHIBIT 10.16 tm225197d11_ex10-16.htm EX-10.16 135865
20 EXHIBIT 10.17 tm225197d11_ex10-17.htm EX-10.17 25894
21 EXHIBIT 10.18 tm225197d11_ex10-18.htm EX-10.18 18283
22 EXHIBIT 10.19 tm225197d11_ex10-19.htm EX-10.19 17915
23 EXHIBIT 10.20 tm225197d11_ex10-20.htm EX-10.20 16247
24 EXHIBIT 10.21 tm225197d11_ex10-21.htm EX-10.21 15945
25 EXHIBIT 10.22 tm225197d11_ex10-22.htm EX-10.22 13723
26 EXHIBIT 10.23 tm225197d11_ex10-23.htm EX-10.23 137481
27 EXHIBIT 10.24 tm225197d11_ex10-24.htm EX-10.24 147628
28 EXHIBIT 10.25 tm225197d11_ex10-25.htm EX-10.25 188740
29 EXHIBIT 21.1 tm225197d11_ex21-1.htm EX-21.1 4016
30 EXHIBIT 23.1 tm225197d11_ex23-1.htm EX-23.1 3300
31 EX-FILING FEES tm225197d11_ex-filingfees.htm EX-FILING FEES 13399
32 GRAPHIC aw_ligand-4c.jpg GRAPHIC 267728
33 GRAPHIC fc_intialdua-4c.jpg GRAPHIC 240362
34 GRAPHIC fc_pipeline-4c.jpg GRAPHIC 151816
35 GRAPHIC lg_structure-4c.jpg GRAPHIC 77899
36 GRAPHIC tb_schemaphase1-4c.jpg GRAPHIC 98034
37 GRAPHIC tb_schemaphase2-4c.jpg GRAPHIC 160144
38 GRAPHIC tm225197d1-org_figure74c.jpg GRAPHIC 734296
39 GRAPHIC tm225197d1-pht_figure34c.jpg GRAPHIC 906906
40 GRAPHIC tm225197d11_ex10-14img01.jpg GRAPHIC 5944
41 GRAPHIC tm225197d11_ex10-20img001.jpg GRAPHIC 69487
42 GRAPHIC tm225197d11_ex10-8img001.jpg GRAPHIC 17336
43 GRAPHIC tm225197d11_ex4-4img001.jpg GRAPHIC 593
44 GRAPHIC tm225197d11_ex4-4img002.jpg GRAPHIC 580
45 GRAPHIC tm225197d6-bc_figure104c.jpg GRAPHIC 215717
46 GRAPHIC tm225197d6-bc_figure134c.jpg GRAPHIC 154857
47 GRAPHIC tm225197d6-bc_figure144c.jpg GRAPHIC 122603
48 GRAPHIC tm225197d6-bc_figure194c.jpg GRAPHIC 155206
49 GRAPHIC tm225197d6-bc_figure234c.jpg GRAPHIC 300477
50 GRAPHIC tm225197d6-bc_mouse4c.jpg GRAPHIC 240135
51 GRAPHIC tm225197d6-bc_rat4c.jpg GRAPHIC 233021
52 GRAPHIC tm225197d6-bc_study4c.jpg GRAPHIC 292807
53 GRAPHIC tm225197d6-fc_dose4clr.jpg GRAPHIC 168353
54 GRAPHIC tm225197d6-fc_sad4c.jpg GRAPHIC 147879
55 GRAPHIC tm225197d6-fc_singleass4c.jpg GRAPHIC 145955
56 GRAPHIC tm225197d6-lc_anpapk4c.jpg GRAPHIC 197325
57 GRAPHIC tm225197d6-lc_figure204c.jpg GRAPHIC 354064
58 GRAPHIC tm225197d6-lc_figure214c.jpg GRAPHIC 167337
59 GRAPHIC tm225197d6-lc_figure224c.jpg GRAPHIC 251294
60 GRAPHIC tm225197d6-lc_singledos4c.jpg GRAPHIC 176097
61 GRAPHIC tm225197d6-org_base4c.jpg GRAPHIC 423227
62 GRAPHIC tm225197d6-org_figure14c.jpg GRAPHIC 141928
63 GRAPHIC tm225197d6-org_figure184c.jpg GRAPHIC 595586
64 GRAPHIC tm225197d6-org_figure84c.jpg GRAPHIC 542064
65 GRAPHIC tm225197d6-org_struc4c.jpg GRAPHIC 361639
66 GRAPHIC tm225197d6-ph_apjr4c.jpg GRAPHIC 584817
67 GRAPHIC tm225197d6-ph_lpair4c.jpg GRAPHIC 226088
68 GRAPHIC tm225197d6-ph_pathogen4c.jpg GRAPHIC 504092
69 GRAPHIC tm225197d6-pht_biased4c.jpg GRAPHIC 318408
70 GRAPHIC tm225197d6-pht_figure114clr.jpg GRAPHIC 349161
71 GRAPHIC tm225197d6-pht_figure174c.jpg GRAPHIC 407681
72 GRAPHIC tm225197d6-pht_gsbr4c.jpg GRAPHIC 446745
73 GRAPHIC tm225197d6-pht_lungs4c.jpg GRAPHIC 294927
74 GRAPHIC tm225197d6-pht_site4c.jpg GRAPHIC 508783
75 GRAPHIC tm225197d6-pht_tree4c.jpg GRAPHIC 911062
76 GRAPHIC tm225197d6-tbl_madco4c.jpg GRAPHIC 251909
77 GRAPHIC tm225197d6-tbl_sadco4c.jpg GRAPHIC 358406
78 GRAPHIC tm225197d6-tbl_teaesrep4c.jpg GRAPHIC 270685
  Complete submission text file 0001104659-23-003415.txt   26170045
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

IRS No.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-269200 | Film No.: 23526173
SIC: 2834 Pharmaceutical Preparations